SEARCH RESULTS FOR: "Tag: ESPR"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(2)
2018(3)
2017(3)
2016(3)
2015(13)
CATEGORIES
Analyst Downgrades(1)
Analyst Update(3)
Analyst Upgrades(1)
Buzz Stocks(3)
Ezines(1)
General(5)
Intraday Option Activity(2)
Midday Market Check(2)
Opening View(1)
Stock Market News(1)
Stocks On the Move(6)
Technical Analysis(1)

5/29/2019 12:56 PM
This morning, Goldman Sachs weighed in on two pharma stocks, downgrading Clovis Oncology Inc (NASDAQ:CLVS) and Esperion Therapeutics Inc (NASDAQ:ESPR) to "sell." Regarding the former, Goldman believes...
5/6/2019 9:55 AM
Near the top of the Nasdaq today sits Esperion Therapeutics Inc (NASDAQ:ESPR), after the Food and Drug Administration (FDA) accepted marketing applications for the company's cholesterol drug. At last...
5/2/2018 3:22 PM
The Nasdaq is outperforming today, thanks to a positive earnings reaction for Apple (AAPL). Nevertheless, drug stocks Akorn, Inc. (NASDAQ:AKRX), Esperion Therapeutics Inc (NASDAQ:ESPR), and Gilead Sc...
3/27/2018 2:03 PM
The Dow is holding higher this afternoon thanks to a strong move from GE stock. Three other names making notable moves today are drug stocks Esperion Therapeutics Inc (NASDAQ:ESPR), Arrowhead Pharm...
3/7/2018 10:12 AM
Drugmakers Aptose Biosciences Inc (NASDAQ:APTO) and Esperion Therapeutics Inc (NASDAQ:ESPR) are both making headlines this morning, but for different reasons. We'll dig into APTO and ESPR stocks b...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center